Inozyme Pharma Stock Target Price and Analyst Consensus
| INZY Stock | USD 2.69 0.10 3.58% |
The current analyst and expert consensus on Inozyme Pharma is Strong Buy, with 6 strong buy opinions. The current projected Inozyme Pharma target price consensus is 21.00 with 9 analyst opinions. Check out Macroaxis Advice on Inozyme Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme Pharma guide.The most common way Inozyme Pharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Inozyme Pharma executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Inozyme Pharma. We strongly encourage you to use your own analysis of Inozyme Pharma to validate this buy or sell advice. Inozyme Pharma buy-or-sell recommendation module provides average expert sentiment on the projected Inozyme Pharma target price to derive its highest and lowest estimates based on projected price volatility of 3.5159.
Lowest Forecast 19.11 | Highest Forecast 23.31 | Target Price 21 |
Inozyme |
It's important to approach Inozyme Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Inozyme Pharma Target Price Consensus
Inozyme target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Inozyme Pharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Strong Buy |
Most Inozyme analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Inozyme stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Inozyme Pharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationInozyme Pharma Target Price Projection
Inozyme Pharma's current and average target prices are 2.69 and 21.00, respectively. The current price of Inozyme Pharma is the price at which Inozyme Pharma is currently trading. On the other hand, Inozyme Pharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Inozyme Pharma Market Quote on 22nd of November 2024
Target Price
Analyst Consensus On Inozyme Pharma Target Price
Inozyme Pharma Analyst Ratings
Inozyme Pharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Inozyme Pharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Inozyme Pharma's financials, market performance, and future outlook by experienced professionals. Inozyme Pharma's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Inozyme Pharma price targets
Inozyme Pharma's stock target price is an estimate of its future price, usually made by analysts. Using Inozyme Pharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at Inozyme Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Inozyme Pharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Inozyme Pharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Inozyme Pharma is a key component of Inozyme Pharma valuation and have some predictive power on the future returns of a Inozyme Pharma.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 200 shares | |
 | Cash Cows Invested few shares | |
 | Momentum Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Driverless Cars Invested over 200 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Electronic Equipment Invested few shares | |
 | Housewares Invested few shares | |
 | Defense Sold few shares | |
 | Cars Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Warren Buffett Holdings Invested over 40 shares | |
Additional Tools for Inozyme Stock Analysis
When running Inozyme Pharma's price analysis, check to measure Inozyme Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme Pharma is operating at the current time. Most of Inozyme Pharma's value examination focuses on studying past and present price action to predict the probability of Inozyme Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme Pharma's price. Additionally, you may evaluate how the addition of Inozyme Pharma to your portfolios can decrease your overall portfolio volatility.